Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

Cell Metabolism

Volumn 4, Issue 2, 2006, Pages 111-121

  Zhao, Chen ^a   Irie, Naoko ^a   Takada, Yasunari ^a   Shimoda, Kouji ^a   Miyamoto, Takeshi ^a   Nishiwaki, Toru ^a   Suda, Toshio ^a   Matsuo, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

SIGNALING

Indexed keywords

EPHRIN; EPHRIN B2; EPHRIN B3; EPHRIN B4; PROTEIN C FOS; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MASS; BONE METABOLISM; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CODE; METABOLIC INHIBITION; METABOLIC REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; EPHRIN-B2; HOMEOSTASIS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPHB4; SIGNAL TRANSDUCTION; UP-REGULATION;

MUS MUSCULUS;

EID: 33746528704     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2006.05.012     Document Type: Article

References (55)

1. Adams R.H., Wilkinson G.A., Weiss C., Diella F., Gale N.W., Deutsch U., Risau W., and Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13 (1999) 295-306
2. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., Morita I., Wagner E.F., Mak T.W., Serfling E., and Takayanagi H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202 (2005) 1261-1269
3. Barton G.M., and Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA 99 (2002) 14943-14945
4. Batlle E., Henderson J.T., Beghtel H., van den Born M.M., Sancho E., Huls G., Meeldijk J., Robertson J., van de Wetering M., Pawson T., and Clevers H. β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111 (2002) 251-263
5. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., and Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8 (1999) 265-277
6. Compagni A., Logan M., Klein R., and Adams R.H. Control of skeletal patterning by ephrinB1-EphB interactions. Dev. Cell 5 (2003) 217-230
7. Cowan C.A., Yokoyama N., Saxena A., Chumley M.J., Silvany R.E., Baker L.A., Srivastava D., and Henkemeyer M. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev. Biol. 271 (2004) 263-271
8. Davy A., and Soriano P. Ephrin signaling in vivo: look both ways. Dev. Dyn. 232 (2005) 1-10
9. Davy A., Aubin J., and Soriano P. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev. 18 (2004) 572-583
10. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
11. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
12. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., and Siebenlist U. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11 (1997) 3482-3496
13. Füller T., Korff T., Kilian A., Dandekar G., and Augustin H.G. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J. Cell Sci. 116 (2003) 2461-2470
14. Gale N.W., and Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13 (1999) 1055-1066
15. Gebbink M.F., Kranenburg O., Poland M., van Horck F.P., Houssa B., and Moolenaar W.H. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J. Cell Biol. 137 (1997) 1603-1613
16. Gerety S.S., and Anderson D.J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129 (2002) 1397-1410
17. Gerety S.S., Wang H.U., Chen Z.F., and Anderson D.J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4 (1999) 403-414
18. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., and Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 (1994) 443-448
19. Harmey D., Stenbeck G., Nobes C.D., Lax A.J., and Grigoriadis A.E. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J. Bone Miner. Res. 19 (2004) 661-670
20. Harris W.H., and Heaney R.P. Skeletal renewal and metabolic bone disease. N. Engl. J. Med. 280 (1969) 253-259
21. Hattner R., Epker B.N., and Frost H.M. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206 (1965) 489-490
22. Hayden J.M., Mohan S., and Baylink D.J. The insulin-like growth factor system and the coupling of formation to resorption. Bone 17 (1995) 93S-98S
23. Himanen J.P., and Nikolov D.B. Eph receptors and ephrins. Int. J. Biochem. Cell Biol. 35 (2003) 130-134
24. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., Kumegawa M., Kimura T., and Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277 (2002) 41147-41156
25. Jaiswal R.K., Jaiswal N., Bruder S.P., Mbalaviele G., Marshak D.R., and Pittenger M.F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275 (2000) 9645-9652
26. Kanzaki S., Ito M., Takada Y., Ogawa K., and Matsuo K. Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone 39 (2006) 414-419
27. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2 (2002) 389-406
28. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
29. Kullander K., and Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3 (2002) 475-486
30. Liu W., Toyosawa S., Furuichi T., Kanatani N., Yoshida C., Liu Y., Himeno M., Narai S., Yamaguchi A., and Komori T. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155 (2001) 157-166
31. Martin T.J. Does bone resorption inhibition affect the anabolic response to parathyroid hormone?. Trends Endocrinol. Metab. 15 (2004) 49-50
32. Matsuo K., Galson D.L., Zhao C., Peng L., Laplace C., Wang K.Z., Bachler M.A., Amano H., Aburatani H., Ishikawa H., and Wagner E.F. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279 (2004) 26475-26480
33. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., and Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6 (2004) 483-495
34. Murai K.K., and Pasquale E.B. 'Eph'ective signaling: forward, reverse and crosstalk. J. Cell Sci. 116 (2003) 2823-2832
35. Myshkin E., and Wang B. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach. J. Chem. Inf. Comput. Sci. 43 (2003) 1004-1010
36. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., and de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
37. Nishiwaki T., Yamaguchi T., Zhao C., Amno H., Hankenson K.D., Bornstein P., Toyama Y., and Matsuo K. Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. J. Bone Miner. Res. 21 (2006) 596-604
38. Noren N.K., and Pasquale E.B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell. Signal. 16 (2004) 655-666
39. Palmer A., and Klein R. Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev. 17 (2003) 1429-1450
40. Parfitt A.M. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 55 (1994) 273-286
41. Pasquale E.B. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 6 (2005) 462-475
42. Pfeilschifter J., and Mundy G.R. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA 84 (1987) 2024-2028
43. Ray N., Kuwahara M., Takada Y., Maruyama K., Kawaguchi T., Tsubone H., Ishikawa H., and Matsuo K. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 18 (2006) 671-677
44. Sharfe N., Freywald A., Toro A., Dadi H., and Roifman C. Ephrin stimulation modulates T cell chemotaxis. Eur. J. Immunol. 32 (2002) 3745-3755
45. Sheu T.-J., Schwarz E.M., Martinez D.A., O'Keefe R.J., Rosier R.N., Zuscik M.J., and Puzas J.E. A phage display technique identifies a novel regulator of cell differentiation. J. Biol. Chem. 278 (2003) 438-443
46. Steinle J.J., Meininger C.J., Forough R., Wu G., Wu M.H., and Granger H.J. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 277 (2002) 43830-43835
47. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3 (2002) 889-901
48. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416 (2002) 744-749
49. Teitelbaum S.L., and Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4 (2003) 638-649
50. Wang F.-S., Wang C.-J., Sheen-Chen S.-M., Kuo Y.-R., Chen R.-F., and Yang K.D. Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J. Biol. Chem. 277 (2002) 10931-10937
51. Wang H.U., Chen Z.F., and Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93 (1998) 741-753
52. Wang Z.Q., Ovitt C., Grigoriadis A.E., Möhle-Steinlein U., Rüther U., and Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature 360 (1992) 741-744
53. Wang Z., Cohen K., Shao Y., Mole P., Dombkowski D., and Scadden D.T. Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels. Blood 103 (2004) 100-109
54. Xiao G., Jiang D., Thomas P., Benson M.D., Guan K., Karsenty G., and Franceschi R.T. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 275 (2000) 4453-4459
55. Yu G., Luo H., Wu Y., and Wu J. Ephrin B2 induces T cell costimulation. J. Immunol. 171 (2003) 106-114